Tested Applications
| Positive WB detected in | mouse liver tissue, human liver tissue, rat liver tissue |
| Positive IHC detected in | human lung cancer tissue, human prostate hyperplasia tissue, human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11855-1-AP targets HSD17B6 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2427 Product name: Recombinant human HSD17B6 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-317 aa of BC020710 Sequence: MWLYLAAFVGLYYLLHWYRERQVVSHLQDKYVFITGCDSGFGNLLARQLDARGLRVLAACLTEKGAEQLRGQTSDRLETVTLDVTKMESIAAATQWVKEHVGDRGLWGLVNNAGILTPITLCEWLNTEDSMNMLKVNLIGVIQVTLSMLPLVRRARGRIVNVSSILGRVAFFVGGYCVSKYGVEAFSDILRREIQHFGVKISIVEPGYFRTGMTNMTQSLERMKQSWKEAPKHIKETYGQQYFDALYNIMKEGLLNCSTNLNLVTDCMEHALTSVHPRTRYSAGWDAKFFFIPLSYLPTSLADYILTRSWPKPAQAV Predict reactive species |
| Full Name | hydroxysteroid (17-beta) dehydrogenase 6 homolog (mouse) |
| Calculated Molecular Weight | 317 aa, 36 kDa |
| Observed Molecular Weight | 33-35 kDa |
| GenBank Accession Number | BC020710 |
| Gene Symbol | HSD17B6 |
| Gene ID (NCBI) | 8630 |
| RRID | AB_2295487 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O14756 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for HSD17B6 antibody 11855-1-AP | Download protocol |
| WB protocol for HSD17B6 antibody 11855-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The HSD17B6 Polyclonal antibody (Cat# 11855-1-AP) has 5 citations published in Cell Death Discovery, Cancer Cell International, Probiotics and Antimicrobial Proteins, Breast Cancer Research and Treatment, and Toxicology Letters. Research fields span lung adenocarcinoma, hepatocellular carcinoma, ulcerative colitis, triple-negative breast cancer, and hepatic steatosis, with applications including Western blot and IHC in human and mouse models.
| Species | Application | Title |
|---|---|---|
Cell Death Discov HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma | ||
Cancer Cell Int Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma. | ||
Probiotics Antimicrob Proteins Enterococcus hirae Y-HS Alleviates Ulcerative Colitis by Activating PXR/Nrf2-mediated Metabolic-immune Crosstalk. | ||
Breast Cancer Res Treat The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer. | ||
Toxicol Lett Metabolomics reveals dysregulated all-trans retinoic acid and polyunsaturated fatty acid metabolism contribute to PXR-induced hepatic steatosis in mice |



















